This 1.25-hour Internet symposium will review and discuss the key studies on antiretroviral therapy presented at the 13th European AIDS Conference (EACS) and the 49th Annual Meeting of the Infectious Disease Society of America (IDSA).
This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals involved in the treatment and management of patients with HIV infection.
After completing this activity, participants should be able to:
Explain the key new studies on ARV therapy presented at the 13th EACS and 49th IDSA
Outline advances in clinical management of HIV-positive patients presented and discussed at the 13th EACS and 49th IDSA to improve patient care;
Describe data presented at the 13th EACS and 49th IDSA regarding the treatment of ARV-naïve and experienced patients;
Construct appropriate ARV regimens for HIV-positive patients.
Release Date: November 5, 2011
Expiration Date: November 5, 2012
Estimated time to complete this on-demand Web symposium: 1 hours, 15 minutes
Media: Internet
| José Arribas, MD Senior Attending Physician, HIV Unit Hospital de La Paz Madrid, Spain |
Edwin DeJesus, MD Medical Director Orlando Immunology Center Orlando, Florida |
| John Bartlett, MD Professor of Medicine, Johns Hopkins School of Medicine Baltimore, Maryland |
Juergen Rockstroh, MD Professor University of Bonn Bonn, Germany |
| Calvin J. Cohen, MD, MS Research Director, CRI New England, Clinical Instructor, Harvard Medical School Boston, Massachusetts |
Paul Sax, MD Clinical Director, Brigham and Women's Division of Infectious Diseases and HIV Program Associate Professor of Medicine, Harvard Medical School Boston, Massachusetts |
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and ViralEd, Inc..
Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Postgraduate Institute for Medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine assesses conflicts of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Postgraduate Institute for Medicine for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Postgraduate Institute for Medicine is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
|
Jose Arribas, MD
|
|
John Bartlett, MD
|
|
Calvin Cohen, MD
|
Edwin DeJesus, MD
|
Juergen Rockstroh, MD
|
Paul Sax, MD
|
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following planners and managers, Jan Hixon, RN, BSN, MA; Trace Hutchinson, PharmD; Julia Kimball, RN, BSN; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP; Patricia Staples, MSN, NP-C, CCRN, Brian Boyle, MD hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
There are no fees for participating and receiving credit for this activity. During the period, November 5, 2011 through November 5, 2012 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form.
To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on the Submit Post-test at the bottom of the page. Your post-test will automatically be graded.
If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.
You may complete the post-test online at: www.cmeuniversity.com
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Supported by an educational grant from Merck & Co., Inc.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings
